What is the appropriate Lovenox (enoxaparin) dose for a 70‑year‑old patient with a blood clot (deep‑vein thrombosis or pulmonary embolism) after a hip fracture?

Lovenox Dosing for VTE Treatment After Hip Fracture in a 70-Year-Old

For a 70-year-old patient with an established blood clot (DVT or PE) after hip fracture, treat with enoxaparin 1 mg/kg subcutaneously every 12 hours, or 1.5 mg/kg once daily if normal renal function (CrCl ≥30 mL/min); reduce to 1 mg/kg once daily if CrCl <30 mL/min. 1, 2

Treatment vs. Prophylaxis: Critical Distinction

Your question specifies treatment of an established blood clot, not prophylaxis. This is a crucial distinction:

• For VTE treatment (what you're asking about): 1 mg/kg every 12 hours or 1.5 mg/kg once daily 1, 3, 2
• For VTE prophylaxis (prevention only): 30 mg every 12 hours or 40 mg once daily 4, 2

The FDA-approved treatment doses are substantially higher than prophylactic doses because you're treating an active thrombosis, not just preventing one 2.

Specific Dosing Algorithm

Step 1: Assess Renal Function

Calculate creatinine clearance (CrCl) - this is mandatory in a 70-year-old:

• CrCl ≥30 mL/min: Standard treatment dosing

  • 1 mg/kg subcutaneously every 12 hours, OR
  • 1.5 mg/kg subcutaneously once daily 1, 2

• CrCl <30 mL/min: Dose reduction required

  • 1 mg/kg subcutaneously once every 24 hours 5, 1, 5, 2
  • This is critical because enoxaparin accumulation increases bleeding risk 2-3 fold in severe renal impairment 5

Step 2: Consider Weight

• Standard dosing applies for most patients
• For patients >120 kg, optimal dosing is less clear, but weight-based dosing should still be used 1
• For patients <50 kg, use caution and consider monitoring anti-Xa levels 5, 3

Step 3: Duration

• Continue therapeutic anticoagulation for at least 3 months for provoked VTE (hip fracture is a major provoking factor) 6
• After initial treatment period, may consider dose reduction (e.g., dalteparin reduces from 200 IU/kg to 150 IU/kg after 1 month) 3, though this is more established for dalteparin than enoxaparin

Age-Specific Considerations for 70-Year-Olds

At age 70, several factors require attention:

• Renal function decline: Even with "normal" creatinine, elderly patients often have reduced CrCl. Calculate it, don't assume 5
• Bleeding risk: Monitor closely, though therapeutic enoxaparin has acceptable bleeding rates in elderly patients 1, 2
• Limited evidence: Data specifically in elderly patients (≥70 years) with renal impairment is sparse 5, 3

Monitoring

• Routine coagulation tests (PT/aPTT) are NOT useful for monitoring enoxaparin 2
• Anti-Factor Xa levels may be used if:
  • Severe renal impairment (CrCl <30 mL/min) 5, 3
  • Extremes of body weight 5, 3
  • Unexpected bleeding or recurrent thrombosis 2
  • Target therapeutic range: 0.5-1.5 IU/mL (measured 4-6 hours post-dose, after 3-4 doses) 5

Common Pitfalls to Avoid

1. Using prophylactic doses for treatment: 30-40 mg doses are for prevention only, not for treating established clots 4, 2

2. Ignoring renal function in elderly: A 70-year-old with "normal" creatinine may still have CrCl <30 mL/min requiring dose adjustment 5

3. Switching between anticoagulants: Don't switch from enoxaparin to UFH or vice versa - increases bleeding risk 7

4. Underdosing: Standard fixed prophylactic doses are inadequate for many trauma patients; therapeutic dosing requires weight-based calculation 8, 9

Bleeding Risk Management

Major bleeding rates with therapeutic enoxaparin are low (1-4%) in clinical trials 2. However:

• Monitor hemoglobin and platelet counts regularly 2
• Check stool for occult blood 2
• Watch for signs of HIT (heparin-induced thrombocytopenia) 2
• Have protamine sulfate available (partially reverses enoxaparin) 2

The key message: For treating an established clot in your 70-year-old hip fracture patient, use full therapeutic doses (1 mg/kg every 12 hours), not prophylactic doses, and always check renal function first.